These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3519552)

  • 41. Clinical studies on the use of radiation therapy as primary treatment of early breast cancer.
    Harris JR; Beadle GF; Hellman S
    Cancer; 1984 Feb; 53(3 Suppl):705-11. PubMed ID: 6362823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomised trials: the case for science in medicine.
    Baum M
    Recent Results Cancer Res; 1988; 111():6-17. PubMed ID: 3051231
    [No Abstract]   [Full Text] [Related]  

  • 43. The role of radiation in breast conserving therapy.
    Wazer DE
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):681-91. PubMed ID: 7731641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation.
    Br J Cancer; 1988 Jun; 57(6):608-11. PubMed ID: 2900647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast.
    Buchholz TA; Haffty BG; Harris JR
    J Surg Oncol; 2007 Jun; 95(8):610-3. PubMed ID: 17221862
    [No Abstract]   [Full Text] [Related]  

  • 46. [Concurrent chemoradiotherapy for advanced breast cancer].
    Karasawa K; Ito K; Hirowatari H; Saito AI; Izawa H
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():402-6. PubMed ID: 17682184
    [No Abstract]   [Full Text] [Related]  

  • 47. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy.
    Fowble B; Gray R; Gilchrist K; Goodman RL; Taylor S; Tormey DC
    J Clin Oncol; 1988 Jul; 6(7):1107-17. PubMed ID: 3292711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer.
    Hu ZI; Ho AY; McArthur HL
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):153-164. PubMed ID: 28816141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer.
    Rutqvist LE; Cedermark B; Glas U; Johansson H; Rotstein S; Skoog L; Somell A; Theve T; Wilking N; Askergren J
    Cancer; 1990 Jul; 66(1):89-96. PubMed ID: 2191764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [New external radiotherapy technologies for breast cancer].
    Falk AT; Fenoglietto P; Azria D; Bourgier C
    Cancer Radiother; 2014 Oct; 18(5-6):480-5. PubMed ID: 25182528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of definitive irradiation on local control and disease free survival in breast cancer.
    Levitt SH; Potish RA; Boen JR; Lindgren B
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):673-9. PubMed ID: 3516956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of postmastectomy radiotherapy in patients with stage II breast cancer.
    Ohri N; Haffty BG; Buchholz TA
    Cancer; 2018 Feb; 124(3):450-452. PubMed ID: 29231966
    [No Abstract]   [Full Text] [Related]  

  • 53. Danish Breast Cancer Cooperative Group (DBCG). Present status and experience.
    Fischerman K; Mouridsen HT
    Acta Chir Scand Suppl; 1984; 519():55-9. PubMed ID: 6393665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial.
    Buzdar AU; Blumenschein GR; Smith TL; Powell KC; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Ames FC; Martin RG
    Cancer; 1984 Feb; 53(3):384-9. PubMed ID: 6362814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiation therapy for breast cancer.
    Bellon JR; Katz A; Taghian A
    Hematol Oncol Clin North Am; 2006 Apr; 20(2):239-57, vii. PubMed ID: 16730294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Wide-field radiation as adjunct to adjuvant chemotherapy in high-risk cases with early breast cancer: do it or not?
    Ragaz J; Spinelli JJ
    Int J Cancer; 2000 Aug; 87(3):423-6. PubMed ID: 10897049
    [No Abstract]   [Full Text] [Related]  

  • 57. [Local recurrence of ductal in situ carcinoma of the breast].
    Dunst J
    Strahlenther Onkol; 1999 Jul; 175(7):348-9. PubMed ID: 10432998
    [No Abstract]   [Full Text] [Related]  

  • 58. [Whole-breast irradiation following breast-conserving surgery of ductal carcinomain situ is indispensable. Update of the 2005 DEGRO (German Society of Radiation Oncology) Guideline on Radiation Therapy for Breast Cancer].
    Souchon R; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sautter Bihl ML; Wenz F; Sauer R;
    Strahlenther Onkol; 2006 Aug; 182(8):429-30. PubMed ID: 16896587
    [No Abstract]   [Full Text] [Related]  

  • 59. Is the NSABP R-03 study in line with other chemoradiation studies?
    Glynne-Jones R; Harrison M; Hughes R
    J Clin Oncol; 2010 Jun; 28(18):e305-6; author reply e307. PubMed ID: 20479393
    [No Abstract]   [Full Text] [Related]  

  • 60. [Current trends in the treatment of primary breast cancer].
    Letiagin VP
    Vopr Onkol; 1998; 44(5):632-5. PubMed ID: 9884732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.